The latest report by IMARC Group, titled ‘Oxygen Therapy Market: Global Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2032,' offers a comprehensive analysis of the oxygen therapy market outlook. The report also includes competitor and regional analysis, along with a breakdown of segments within the industry.

The global oxygen therapy market size reached US$ 18.9 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 33.5 Billion by 2032, exhibiting a growth rate (CAGR) of 6.4% during 2024-2032.

Request a Sample Report: https://www.imarcgroup.com/oxygen-therapy-market/requestsample

Oxygen Therapy Market Trends:

The global oxygen therapy market is driven by the rising prevalence of respiratory diseases such as chronic obstructive pulmonary disease (COPD), asthma, and pneumonia significantly increases the demand for oxygen therapy. Concurrently, the aging global population, which is more susceptible to chronic respiratory conditions, further propels market expansion. Along with this, technological advancements in oxygen therapy equipment, including portable and wearable devices, enhance patient convenience and compliance, driving market adoption. In addition, the increasing healthcare expenditures and improved healthcare infrastructure in emerging economies support market growth. The rise in the number of patients requiring long-term oxygen therapy due to chronic conditions is another crucial driver. Apart from this, the growing awareness about the benefits of oxygen therapy in improving the quality of life for patients with hypoxemia bolsters market demand. Moreover, favorable reimbursement policies for oxygen therapy equipment and services facilitate wider access and adoption.

Oxygen Therapy Market Scope and Growth Analysis:

The scope of the global market encompasses a diverse range of applications and technological innovations, indicating robust growth potential. In the home healthcare sector, oxygen therapy is increasingly adopted for managing chronic respiratory conditions, providing patients with greater mobility and comfort through portable oxygen concentrators. As per the market analysis, the market is also expanding in the hospital and clinical settings, where advanced oxygen delivery systems and high-flow nasal cannula therapy are used for acute care.

Technological advancements are leading to the development of user-friendly and efficient oxygen therapy devices, enhancing patient compliance and treatment outcomes. Besides this, the increasing prevalence of respiratory diseases in emerging markets is driving demand for oxygen therapy solutions, supported by improving healthcare infrastructure and rising healthcare spending. Additionally, the integration of telemedicine with oxygen therapy devices is emerging as a new trend, offering remote monitoring and management of patients. Furthermore, continuous innovations and the growing need for effective respiratory care solutions are expanding the application scope of oxygen therapy.

View Full Report with TOC & List of Figure: https://www.imarcgroup.com/oxygen-therapy-market

Competitive Landscape:

The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.

  • Allied Healthcare Products Inc.
  • Becton Dickinson and Company
  • DeVilbiss Healthcare LLC (Drive Medical Inc.)
  • Fisher & Paykel Healthcare Limited
  • General Electric Company
  • Getinge AB
  • Hersill SL
  • Invacare Corporation
  • Koninklijke Philips N.V
  • Smiths Group plc
  • Tecno-Gaz S.p.A.
  • Teleflex Incorporated.

Oxygen Therapy Market Segmentation:

Our report has categorized the market based on region, product, application and end use.

Breakup by Product:

  • Oxygen Source Equipment
    • Oxygen Cylinders
    • Oxygen Concentrators
    • Liquid Oxygen Devices
    • PAP Devices
  • Oxygen Delivery Devices
    • Oxygen Masks
    • Nasal Cannula
    • Venturi Masks
    • Non-rebreather Masks
    • Bag Valve Masks
    • CPAP Masks
    • Others 

Breakup by Application:

  • Chronic Obstructive Pulmonary Disease
  • Asthma
  • Obstructive Sleep Apnea
  • Respiratory Distress Syndrome
  • Cystic Fibrosis
  • Pneumonia
  • Others

Breakup by End Use:

  • Home Healthcare
  • Hospitals 

Breakup by Region:

  • North America (United States, Canada)
  • Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
  • Asia Pacific (China, Japan, India, Australia, Indonesia, South Korea, Others)
  • Latin America (Brazil, Mexico, Argentina, Colombia, Chile, Peru, Others)
  • Middle East and Africa (Turkey, Saudi Arabia, Iran, United Arab Emirates, Others)

Key Highlights of the Report:

  • Market Performance (2018-2023)
  • Market Outlook (2024-2032)
  • Porter’s Five Forces Analysis
  • Market Drivers and Success Factors
  • SWOT Analysis
  • Value Chain
  • Comprehensive Mapping of the Competitive Landscape

About US:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic, and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact US:

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

Email: sales@imarcgroup.com

Tel No:(D) +91 120 433 0800

United States: +1-631-791-1145 | United Kingdom: +44-753-713-2163